The ACT EU workplan for 2026-2027 is now available. The revised workplan is aligned with the updated ACT EU objectives. It is informed by key EU legislative and policy initiatives shaping the clinical trials environment, including the proposed Biotech Act, the Clinical Research Investment Plan (part of the Strategy for European Life Sciences) and the EU4Health initiatives. The document highlights ACT EU’s areas of focus, taking into account the feedback received through the multi-stakeholder platform advisory group and other channels. New focus areas include: For more details, see:ACT EU workplan 2026-2027
ACT EU - Accelerating Clinical Trials · May 08, 2026
ACT EU workplan for 2026-2027 and updated objectives published
Original title: ACT EU workplan for 2026-2027 & updated objectives published
ACT EU published its 2026-2027 workplan aligned with updated objectives, informed by the proposed Biotech Act, Clinical Research Investment Plan and EU4Health initiatives.
Published by ACT EU - Accelerating Clinical Trials. HealthSignal links to the original document; the summary above is extracted from the source text.